Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 58 (-6.5%)Axles India₹ 525 (6.1%)Bira ₹ 108 (0%)CIAL ₹ 438 (0%)CSK ₹ 266 (3.1%)ESDS Software₹ 448 (0.7%)Garuda Aerospace₹ 485 (0%)GFCL EV₹ 42 (0%)Hero Fincorp₹ 1075 (2.4%)HPX India₹ 28 (7.7%)Incred Holdings₹ 150 (1.4%)India Carbon₹ 895 (0%)Indian Potash₹ 2850 (3.6%)Inox Clean₹ 725 (-8.8%)Insolare Energy₹ 185 (0%)Lava ₹ 52 (8.3%)Matrix Gas₹ 16 (0%)Motilal Oswal₹ 12.95 (12.6%)MSEI ₹ 6.25 (-3.8%)NCDEX ₹ 388 (-4.2%)NeRL ₹ 58 (0%)NSE ₹ 1975 (2.6%)Onix Renewable₹ 66 (13.8%)Orbis Financial₹ 408 (0.7%)OYO ₹ 24 (0%)Pharmeasy ₹ 6.25 (-3.8%)Polymatech Electronics₹ 62 (-3.1%)RRP S4E₹ 168 (0%)SBI Mutual₹ 775 (0%)Ticker Ltd₹ 32 (0%)Zepto ₹ 49 (-9.3%)

15 Days Price Change

Ravelcare IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2018 Industry: Trading Listed Page

Profile
Issue Size 17.28 Cr
Profile
Price Range 123  to  130 per share
Profile
Min Investment ₹130
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Our Company specializes in personalized haircare, skincare and bodycare products within the beauty and personal care industry. Our core mission is to redefine beauty standards by offering bespoke products meticulously crafted to meet the needs and preferences of customers. We focus on harnessing top-tier ingredients, cutting-edge product research, and direct customer feedback to curate exceptional formulations that deliver transformative results. Our dedication to personalized beauty regimens empowers individuals to embrace their distinctiveness and enhances their self-assurance. We aim to foster a movement towards personalized self-care by revolutionizing how people perceive and engage with beauty, thereby enhancing the overall customer experience. We believe that our marketing strategy is powered by our customer centric approach across various aspects of our business model, including our digital distribution channel and our data driven marketing and consumer engagement model. Read More

Basic Info

Face Value 10 per share

Price 123  to  130 per share

P/E (x) 12.4

Sales( Cr.) 25

PAT( Cr.) 5

EPS 10.5

Draft Prospectus

Exchange BSE-SME

Promoter

Company Promoters

Ayush Mahesh Varma Maheshkumar Ramchandra Varma Anita Mahesh Varma

Pre Issue Share Holding 99.96%

Post Issue Share Holding 72.94%

Listing Details:

Listing Price: 201

Listing Gain: 35.32%

Current Price: 192

Gain On Issue: 192 | 0%

GMP: 75

GMP %: 57.7 %

IPO Tentative Timetable

Opening Date Dec 01, 2025
Closing Date Dec 03, 2025
Allotment Dec 04, 2025
Refund Dec 05, 2025
Delivery of Shares Dec 05, 2025
Listing Date Dec 08, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2000 260,000
Retail (Max) -- -- --
S-HNI (Min) 1 2000 260,000
S-HNI (Max) 3 6000 780,000
B-HNI (Min) 4 8000 1,040,000

Objective of the Issue

1. Marketing and advertisement expenses toward enhancing the awareness and visibility of our brand2. Setting up a new manufacturing facility at Mauje-Peth in Amravati (“Proposed facility”)3. General corporate purposes

Issue

Category Nos Bid Bid (x)
QIB 351000 54725000 155.9x
NII 358000 198664000 554.9x
Retail 620000 287138000 463.1x
EMP 0 0 0x
Total 1329000 540527000 406.7x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Ravelcare Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 1 3 22 25
Other Income 0 0 0 0
Total Income 1 3 22 25
Total Expenditure 1 3 15 18
Operating Profit -0 1 7 7
Interest 0 0 0 0
Depreciation 0 0 0 0
Exceptional Income / Expenses -0 0 0 0
Profit Before Tax -0 1 7 7
Provision for Tax 0 0 2 2
Profit After Tax -0 0 5 5
Adjustments 0 0 0 0
Profit After Adjustments -0 0 5 5
Adjusted Earnings Per Share -0.6 0.8 10 10.5

Ravelcare Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds -0 0 5 10
Minority's Interest 0 0 0 0
Borrowings 0 0 0 0
Other Non-Current Liabilities 0 0 0 -0
Total Current Liabilities 0 2 4 3
Total Liabilities 0 2 9 13
Fixed Assets 0 0 0 0
Other Non-Current Assets 0 0 7 6
Total Current Assets 0 2 2 7
Total Assets 0 2 9 13

Ravelcare Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 1 0
Cash Flow from Operating Activities -0 1 6 -1
Cash Flow from Investing Activities 0 -0 -7 1
Cash Flow from Financing Activities 0 -0 -0 -0
Net Cash Inflow / Outflow -0 1 -1 1
Closing Cash & Cash Equivalent 0 1 0 1

Ravelcare Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -0.56 0.83 10.04 10.48
CEPS(Rs) -0.56 0.83 0 10.68
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) -0.8 0.14 10.18 20.67
Core EBITDA Margin(%) -27.57 14.58 30.52 27.45
EBIT Margin(%) -27.67 14.57 31.28 28.32
Pre Tax Margin(%) -28.58 14.5 30.83 28.16
PAT Margin (%) -35.75 11.89 22.75 21.01
Cash Profit Margin (%) -35.7 11.91 22.85 21.4
ROA(%) -385.64 45.78 89.78 46.95
ROE(%) 0 0 194.42 67.97
ROCE(%) -1322.42 206.07 246.23 91.42
Receivable days 0 0 2.73 19.3
Inventory Days 0 66.38 8.83 13.89
Payable days 0 74.51 44.99 56.22
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.53 -0.16 -0 0.17
EV/Core EBITDA(x) -1.91 -1.12 -0.01 0.6
Net Sales Growth(%) 0 343.01 532.24 13.09
EBIT Growth(%) 0 333.23 1257.61 2.4
PAT Growth(%) 0 247.32 1109.75 4.45
EPS Growth(%) 0 247.33 1109.71 4.45
Debt/Equity(x) -1.04 5.62 0.01 0
Current Ratio(x) 0.17 1.03 0.54 2.61
Quick Ratio(x) 0.17 0.65 0.44 2.04
Interest Cover(x) -30.31 203.56 69.02 172.13
Total Debt/Mcap(x) 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 14% 192% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 68% 87% 66% 66%
ROCE Average 91% 181% -195% -195%

Company Contact Information

Ravelcare Ltd.

Esha Srivastava

+91 8433980120

esha@ravelcare.com

Off-126, Neo Corporate Plaza Cabin B, Ramchandra Lane Extension Malad (West)

IPO Lead Manager(s)

Ravelcare Ltd.

Marwadi Chandarana Intermediaries Brokers Pvt Ltd.

Registrar Info

Ravelcare Ltd.

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District, Nanakramguda Hyderabad – 500032 Tel. No. 040 67161500 Fax. No. 040 23001153 E-mail: einward.ris@karvy.com Website: www.karvy.com Toll Free No. of exclusive Call Centre:1-800-345001

040 - 67162222/18003094001

einward.ris@kfintech.com

https://www.kfintech.com

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!